JW Shinyak Corporation (KOSDAQ:067290)
South Korea
· Delayed Price · Currency is KRW 2,065.00
-15.00 (-0.72%)
At close: Mar 6, 2026
JW Shinyak Revenue
JW Shinyak had revenue of 20.59B KRW in the quarter ending September 30, 2025, a decrease of -34.66%. This brings the company's revenue in the last twelve months to 76.02B, down -25.04% year-over-year. In the year 2024, JW Shinyak had annual revenue of 93.01B, down -10.77%.
Revenue (ttm)
76.02B
Revenue Growth
-25.04%
P/S Ratio
1.44
Revenue / Employee
415.43M
Employees
183
Market Cap
109.23B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 93.01B | -11.22B | -10.77% |
| Dec 31, 2023 | 104.23B | 1.52B | 1.48% |
| Dec 31, 2022 | 102.71B | 1.74B | 1.73% |
| Dec 31, 2021 | 100.97B | -2.84B | -2.73% |
| Dec 31, 2020 | 103.80B | 1.27B | 1.24% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| OSTEONIC | 42.11B |
| Sewoon Medical | 62.13B |
| SCL Science | 16.32B |
| Wonbiogen | 34.38B |
| DuChemBIO | 37.25B |
| CG MedTech | 45.59B |
| KM Corporation | 133.05B |
| MEDYSSEY Co.,Ltd | 10.60B |